Cuproptosis in Triple-Negative Breast Cancer: Current Insights, Limitations and Copper-Related Therapeutic Perspectives
Cancers · 12.11.2026 · 18 (22) · 3613
DOI: 10.3390/cancers18223613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 12.11.2026. Verfasst von Huizheng Xie und 4 weiteren Autor:innen. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Cuproptosis, a recently identified form of copper-dependent regulated cell death, is closely associated with mitochondrial metabolism and copper homeostasis. Triple-negative breast cancer (TNBC) remains difficult to treat because of limited targeted therapeutic options and frequent therapeutic resistance. Emerging evidence suggests that cuproptosis-related pathways may influence TNBC progression, treatment response, and the tumor immune microenvironment. Preclinical studies further indicate that combining cuproptosis-targeting strategies with chemotherapy, targeted therapy, or immunotherapy may enhance anti-tumor efficacy. In this review, we summarize the molecular mechanisms of cuproptosis and its potential roles in TNBC progression, drug resistance, and immune regulation. We also discuss emerging therapeutic strategies targeting cuproptosis and their potential combination with existing treatments in TNBC. Finally, we highlight current challenges and future directions for the clinical translation of cuproptosis-based therapies in TNBC. Collectively, cuproptosis represents a promising but still evolving therapeutic vulnerability that requires further mechanistic and clinical validation.
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
Zitieren
APA
Xie, H., Sun, S., Zhang, L., Xie, W., & Cui, J. (2026). Cuproptosis in Triple-Negative Breast Cancer: Current Insights, Limitations and Copper-Related Therapeutic Perspectives. Cancers, 18(22), 3613. https://doi.org/10.3390/cancers18223613
Vancouver
Xie H, Sun S, Zhang L, Xie W, Cui J. Cuproptosis in Triple-Negative Breast Cancer: Current Insights, Limitations and Copper-Related Therapeutic Perspectives. Cancers. 2026;18(22):3613. doi:10.3390/cancers18223613
BibTeX
@article{Xie2026,
author = {Xie, Huizheng and Sun, Songyao and Zhang, Lijia and Xie, Wenlong and Cui, Jiajun},
title = {Cuproptosis in Triple-Negative Breast Cancer: Current Insights, Limitations and Copper-Related Therapeutic Perspectives},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3613},
doi = {10.3390/cancers18223613}
}
EUVIMED